搜索临床试验以:progression free survival (PFS)
总计12001个结果
-
Peking University People's HospitalXijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital; Peking University... 和其他合作者撤销
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Lei LiBeijing Hospital; China-Japan Friendship Hospital; Navy General Hospital, Beijing; Seventh Medical...未知生活质量 | 上皮性卵巢癌 | 化疗引起的中性粒细胞减少症 | 总生存期 | 无进展生存期 | 药物引起的发热性中性粒细胞减少症 | 集落刺激因子不良反应 | 粒细胞集落刺激因子 | 成本效益分析中国
-
Juan M Garcia-GomezOslo University Hospital; Hospital Clinic of Barcelona; University of Liege; Hospital de Manises; Azienda... 和其他合作者完全的
-
University Hospital, ToulouseDana-Farber Cancer Institute; Celgene Corporation; Janssen-Cilag Ltd.完全的
-
Mundipharma Research Limited终止
-
Wei JiangWuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital... 和其他合作者未知
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)未知卵巢子宫内膜样腺癌 | 卵巢浆液性癌 | 卵巢透明细胞腺癌 | 卵巢粘液腺癌 | 输卵管移行细胞癌 | 卵巢移行细胞癌 | 输卵管透明细胞腺癌 | 输卵管子宫内膜样腺癌 | 输卵管粘液腺癌 | 输卵管浆液性腺癌 | 恶性卵巢布伦纳瘤 | 卵巢浆液性腺癌 | 原发性腹膜浆液性腺癌 | IIA 期输卵管癌 AJCC v6 和 v7 | IIA 期卵巢癌 AJCC V6 和 v7 | IIB 期输卵管癌 AJCC v6 和 v7 | IIB 期卵巢癌 AJCC v6 和 v7 | IIC 期输卵管癌 AJCC v6 和 v7 | IIC 期卵巢癌 AJCC v6 和 v7 | IIIA 期输卵管癌 AJCC v7 | IIIA 期卵巢癌 AJCC v6 和 v7 | IIIA 期原发性腹膜癌 AJCC v7 | IIIB 期输卵管癌 AJCC v7 及其他条件美国
-
Qingdao Central Hospital完全的
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb终止
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...Sanofi撤销结直肠癌转移 | 肝转移 | KRAS突变结直肠癌
-
Zentralklinik Bad Berka完全的
-
Gesellschaft fur Medizinische Innovation - Hamatologie...iOMEDICO AG完全的
-
Chinese Academy of SciencesGuangdong Academy of Medical Sciences; West China Hospital; Shanghai Pulmonary Hospital, Shanghai...未知
-
National Cancer Institute (NCI)完全的
-
European Organisation for Research and Treatment...Roche Pharma AG; Amgen终止结直肠癌转移 | 肝转移 | KRAS野生型结直肠癌法国, 比利时, 奥地利, 荷兰, 西班牙, 瑞士
-
Heinrich-Heine University, Duesseldorf未知
-
Fundación Leucemia y Linfoma, SpainRoche Pharma AG完全的
-
Central European Society for Anticancer Drug Research完全的